ATE93144T1 - Methode zur verminderung der immunglobulin-ereaktion. - Google Patents

Methode zur verminderung der immunglobulin-ereaktion.

Info

Publication number
ATE93144T1
ATE93144T1 AT89300872T AT89300872T ATE93144T1 AT E93144 T1 ATE93144 T1 AT E93144T1 AT 89300872 T AT89300872 T AT 89300872T AT 89300872 T AT89300872 T AT 89300872T AT E93144 T1 ATE93144 T1 AT E93144T1
Authority
AT
Austria
Prior art keywords
ereaction
reducing immunoglobulin
antagonist
human interleukin
immunoglobulin
Prior art date
Application number
AT89300872T
Other languages
English (en)
Inventor
Robert L Coffman
Vries Jan Egbert De
Original Assignee
Schering Biotech Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22538655&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE93144(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Biotech Corp filed Critical Schering Biotech Corp
Application granted granted Critical
Publication of ATE93144T1 publication Critical patent/ATE93144T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244—Interleukins [IL]
    • C07K16/247—IL-4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT89300872T 1988-02-02 1989-01-30 Methode zur verminderung der immunglobulin-ereaktion. ATE93144T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15141388A 1988-02-02 1988-02-02
EP89300872A EP0327283B1 (de) 1988-02-02 1989-01-30 Methode zur Verminderung der Immunglobulin-E-Reaktion

Publications (1)

Publication Number Publication Date
ATE93144T1 true ATE93144T1 (de) 1993-09-15

Family

ID=22538655

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89300872T ATE93144T1 (de) 1988-02-02 1989-01-30 Methode zur verminderung der immunglobulin-ereaktion.

Country Status (20)

Country Link
US (1) US5676940A (de)
EP (2) EP0397764A1 (de)
JP (1) JPH03500050A (de)
KR (1) KR900700132A (de)
AT (1) ATE93144T1 (de)
AU (1) AU629536B2 (de)
CA (1) CA1341477C (de)
DE (1) DE68908431T2 (de)
DK (1) DK183590A (de)
ES (1) ES2058490T3 (de)
FI (1) FI903827A0 (de)
HK (1) HK35196A (de)
HU (1) HU211059B (de)
IE (1) IE63097B1 (de)
IL (1) IL89124A (de)
MY (1) MY107079A (de)
NZ (1) NZ227812A (de)
PT (1) PT89573B (de)
WO (1) WO1989006975A1 (de)
ZA (1) ZA89766B (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU643427B2 (en) * 1988-10-31 1993-11-18 Immunex Corporation Interleukin-4 receptors
HUT64481A (en) * 1989-12-04 1994-01-28 Schering Corp Method for producing pharmaceutical preparative containing human il-6 antagonist
KR960016862B1 (ko) * 1989-12-20 1996-12-23 쉐링 코포레이션 사람 인터루킨-4의 특정 잔기 서열로 이루어진 폴리펩타이드 및 이에 대한 항체의 제조방법
US5252677A (en) * 1990-11-20 1993-10-12 Mitsubishi Petrochemical Company Limited Functionalized olefin polymers
DE4137333A1 (de) * 1991-11-13 1993-05-19 W Prof Dr Sebald Therapeutische mittel, die antagonisten oder partielle agonisten des humanen interleukin 4 sind oder diese enthalten, hil-4-mutantenproteine sowie vefahren zu deren herstellung
US20020193575A1 (en) * 1993-09-07 2002-12-19 Smithkline Beecham P.L.C. Recombinant IL4 antibodies useful in treatment of IL4 mediated disorders
US5928904A (en) * 1993-09-07 1999-07-27 Smithkline Beecham Corporation DNA encoding recombinant IL4 antibodies useful in treatment of IL4 mediated disorders
US5914110A (en) * 1993-09-07 1999-06-22 Smithkline Beecham Corporation Recombinant IL4 antibodies useful in treatment of IL4 mediated disorders
US5597710A (en) * 1994-03-10 1997-01-28 Schering Corporation Humanized monoclonal antibodies against human interleukin-4
US6911462B2 (en) 1998-05-22 2005-06-28 Avanir Pharmaceuticals Benzimidazole compounds for regulating IgE
US6919366B2 (en) 1998-05-22 2005-07-19 Avanir Pharmaceuticals Benzimidazole derivatives as modulators of IgE
US6759425B2 (en) 1999-10-21 2004-07-06 Avanir Pharmaceuticals Benzimidazole compounds for modulating IgE and inhibiting cellular proliferation
PT2990420T (pt) 2000-05-26 2017-03-16 Immunex Corp Uso de anticorpos de recetor de interleucina-4 e composições dos mesmos
CN1496257A (zh) 2001-03-12 2004-05-12 ������˹ҩƷ��˾ 调控免疫球蛋白e及抑制细胞增殖的苯并咪唑化合物
TWI276631B (en) 2002-09-12 2007-03-21 Avanir Pharmaceuticals Phenyl-aza-benzimidazole compounds for modulating IgE and inhibiting cellular proliferation
WO2004024655A2 (en) 2002-09-12 2004-03-25 Avanir Pharmaceuticals Phenyl-indole compounds for modulating ige and inhibiting cellular proliferation
AR050044A1 (es) 2004-08-03 2006-09-20 Novartis Ag Anticuerpo especifico de il-4
US10196616B2 (en) 2017-02-15 2019-02-05 The United States Of America, As Represented By The Secretary Of Agriculture Altered avian virus for in-ovo inoculation and methods of use thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5017691A (en) * 1986-07-03 1991-05-21 Schering Corporation Mammalian interleukin-4
US5041381A (en) * 1986-07-03 1991-08-20 Schering Corporation Monoclonal antibodies against human interleukin-4 and hybridomas producing the same
PT83761B (pt) * 1985-11-19 1989-06-30 Schering Biotech Corp Metodo para a producao de interleuquina-4 de mamifero
EP0255547A1 (de) * 1986-07-29 1988-02-10 Kishimoto, Tadamitsu, Prof. Monoklonale Antikörper spezifisch gegen Oberflächen-IgE-Rezeptor, sowie Hybrid-Zellinien zur Herstellung und Verwendung dieser Antikörper
DE3853636T3 (de) * 1987-12-31 1999-04-08 Tanox Biosystems, Inc., Houston, Tex. Antigene epitope, die sich ausschliesslich auf ige-tragenden b-lymphocyten befinden.

Also Published As

Publication number Publication date
IE63097B1 (en) 1995-03-22
IL89124A0 (en) 1989-08-15
KR900700132A (ko) 1990-08-11
DE68908431D1 (de) 1993-09-23
JPH03500050A (ja) 1991-01-10
IE890302L (en) 1989-08-02
US5676940A (en) 1997-10-14
IL89124A (en) 1994-10-21
CA1341477C (en) 2005-03-29
EP0397764A1 (de) 1990-11-22
AU629536B2 (en) 1992-10-08
HU211059B (en) 1995-10-30
DE68908431T2 (de) 1993-12-23
NZ227812A (en) 1991-09-25
MY107079A (en) 1995-09-30
HU891044D0 (en) 1990-11-28
HK35196A (en) 1996-03-08
DK183590D0 (da) 1990-08-01
PT89573A (pt) 1989-10-04
WO1989006975A1 (en) 1989-08-10
AU3038389A (en) 1989-08-25
HUT54214A (en) 1991-01-28
ZA89766B (en) 1989-09-27
EP0327283B1 (de) 1993-08-18
PT89573B (pt) 1994-01-31
ES2058490T3 (es) 1994-11-01
DK183590A (da) 1990-09-27
FI903827A0 (fi) 1990-08-01
EP0327283A1 (de) 1989-08-09

Similar Documents

Publication Publication Date Title
ATE93144T1 (de) Methode zur verminderung der immunglobulin-ereaktion.
NL300387I1 (nl) Antilichaam tegen menselijke interleukine-6-receptor
DK388384D0 (da) Monoklone antistoffer med specifitet for membran-associerede antigene, deres fremstilling og anvendelse
ATE98872T1 (de) Antagonist fuer interleukin-5 zur verhuetung oder verminderung von eosinophilie.
ES2062762T3 (es) Metodo para tratar el choque septico.
FI924278A0 (fi) Bcrf1 antagonister foer skoetsel av epstein-barr-virusinfektioner.
ATE59860T1 (de) Antileishmania monoklonale antikoerper, diese antikoerper ausscheidende hybridomas, von diesen antikoerpern erkannte leishmaniaantigene, verfahren zur herstellung und verwendung von diesen monoklonalen antikoerpern und antigenen.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EEIH Change in the person of patent owner
RZN Patent revoked